| scholarly article | Q13442814 |
| P50 | author | Charles N Serhan | Q87981947 |
| P2093 | author name string | Jesper Z Haeggström | |
| Paul C Norris | |||
| Ashley E Shay | |||
| Mieke A Soens | |||
| Charlotte C Jouvene | |||
| P2860 | cites work | Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 |
| Common structural features of MAPEG -- a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism | Q24672755 | ||
| Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase | Q27646754 | ||
| Crystal Structures of Leukotriene C4 Synthase in Complex with Product Analogs: IMPLICATIONS FOR THE ENZYME MECHANISM | Q27681069 | ||
| Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis | Q28193495 | ||
| Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1 | Q28249812 | ||
| Structure and function of the spleen | Q28264813 | ||
| Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production | Q28268731 | ||
| Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3 | Q28550214 | ||
| Leukotrienes and lipoxins: structures, biosynthesis, and biological effects | Q29617543 | ||
| Resolvin E1 and protectin D1 activate inflammation-resolution programmes | Q29618679 | ||
| Pro-resolving lipid mediators are leads for resolution physiology | Q30829097 | ||
| Resolvin Infectious Inflammation by Targeting the Host Response | Q33907965 | ||
| Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. | Q34342309 | ||
| A comparison of the enzymatic and physicochemical properties of human glutathione transferase M4-4 and three other human Mu class enzymes | Q34342540 | ||
| Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. | Q34453746 | ||
| Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS. | Q34457553 | ||
| Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways | Q34464346 | ||
| Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection | Q34480905 | ||
| Biosynthesis of D-Series Resolvins in Skin Provides Insights into their Role in Tissue Repair | Q88111937 | ||
| Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain | Q90671281 | ||
| Leukotriene biosynthetic enzymes as therapeutic targets | Q90946845 | ||
| Key roles for lipid mediators in the adaptive immune response | Q90946849 | ||
| Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma | Q34986906 | ||
| The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats | Q35216463 | ||
| Baking reduces prostaglandin, resolvin, and hydroxy-fatty acid content of farm-raised Atlantic salmon (Salmo salar) | Q35567528 | ||
| Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment | Q36049293 | ||
| Long chain fatty acids and related pro-inflammatory, specialized pro-resolving lipid mediators and their intermediates in preterm human milk during the first month of lactation | Q36413939 | ||
| The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype | Q36945083 | ||
| Neuroprotectin/protectin D1 protects against neuropathic pain in mice after nerve trauma | Q37216769 | ||
| An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques | Q37282266 | ||
| Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial | Q37363551 | ||
| Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages | Q37379884 | ||
| Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. | Q37440655 | ||
| Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. | Q37545061 | ||
| Orchestration of metabolism by macrophages | Q38000642 | ||
| The three-dimensional structure of a glutathione S-transferase from the mu gene class. Structural analysis of the binary complex of isoenzyme 3-3 and glutathione at 2.2-A resolution | Q38325077 | ||
| Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation. | Q38610507 | ||
| New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration | Q38627502 | ||
| Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors | Q39197238 | ||
| The GlutathioneS-Transferases: A Group of Multifunctional Detoxification Proteins | Q39719839 | ||
| The Protectin PCTR1 Is Produced by Human M2 Macrophages and Enhances Resolution of Infectious Inflammation | Q39905775 | ||
| Activation of autophagy in macrophages by pro-resolving lipid mediators. | Q39961845 | ||
| Altered pain perception and inflammatory response in mice lacking prostacyclin receptor | Q40646776 | ||
| Catalytic characterization of human microsomal glutathione S-transferase 2: identification of rate-limiting steps | Q41412738 | ||
| The role of prostaglandins in the nociceptive response induced by intraperitoneal injection of zymosan in mice | Q41841194 | ||
| Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages | Q41940013 | ||
| Infection regulates pro-resolving mediators that lower antibiotic requirements | Q42095762 | ||
| Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression | Q43039392 | ||
| Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity | Q47215351 | ||
| Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial. | Q47367164 | ||
| Recent advances in clinical development of leukotriene B4 pathway drugs | Q47892193 | ||
| Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial. | Q47897874 | ||
| Tandem Benzophenone Amino Pyridines, Potent and Selective Inhibitors of Human Leukotriene C4 Synthase. | Q51339322 | ||
| Identification and Complete Stereochemical Assignments of the New Resolvin Conjugates in Tissue Regeneration in Human Tissues that Stimulate Proresolving Phagocyte Functions and Tissue Regeneration. | Q52640025 | ||
| Analysis of the molecular mechanism of substrate-mediated inactivation of leukotriene A4 hydrolase. | Q54135318 | ||
| Specialised pro-resolving mediators of inflammation in inflammatory arthritis | Q57254066 | ||
| GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain | Q57990320 | ||
| Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation | Q60300436 | ||
| Combatting Sepsis: A Public Health Perspective | Q64137591 | ||
| MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes | Q67267224 | ||
| Specificity of the glutathione S-transferases in the conversion of leukotriene A4 to leukotriene C4 | Q69815734 | ||
| Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton | Q79984156 | ||
| Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation | Q84847121 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 12 | |
| P304 | page(s) | 13794-13807 | |
| P577 | publication date | 2019-10-05 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Biosynthetic metabolomes of cysteinyl-containing immunoresolvents | |
| P478 | volume | 33 |
Search more.